Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
normal immunoglobulin, Quantity: 100 mg/mL
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
normal immunoglobulin
Injection, intravenous infusion
Excipient Ingredients: dilute hydrochloric acid; sodium hydroxide; glycine; water for injections
Intravenous Infusion
Single
(S4) Prescription Only Medicine
Replacement therapy in. * Primary Immunodeficiency Diseases. * Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. Immunomodulation. * Idiopathic thrombocytopenic purpura, in adults or children at high risk of bleeding or prior to surgery to correct the platelet count.. * Guillain Barre syndrome. * Kawasaki disease.
Visual Identification: Clear to slightly opalescent and colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type II Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2016-10-13